ASX Announcement ASX : ENP 7 October 2026 First patient successfully completes 60-minute TRP-8803 infusion in Phase 2 Binge Eating Disorder study Melbourne, Australia – Entropy Neurodynamics Limited (‘Entropy Neurodynamics’ or the ‘Company’) (ASX: ENP), a clinical-stage biotechnology...